IDEXX Laboratories, Inc. IDXX is well-poised to grow in the upcoming quarters due to the strong momentum in its CAG (Companion Animal Group) Diagnostics business. The company is also growing its ...
IDEXX Laboratories, Inc. IDXX is well-poised to grow in the upcoming quarters due to the performance of its CAG (Companion Animal Group) Diagnostics business. The consistent growth in international ...
IDEXX Laboratories IDXX has shown remarkable momentum, rallying 64.7% in the last 12 months. The stock has comfortably surpassed the industry’s 2.8% growth and the S&P 500 Composite’s 17.7% gain.
IDEXX LaboratoriesIDXX has shown remarkable momentum so far this year, climbing 75.6%. The stock outperformed the industry’s 4.2% rise and the S&P 500 composite’s 18.5% gain. Carrying a Zacks Rank #3 ...
IDEXX Laboratories, Inc.’s IDXX strong momentum in its CAG (Companion Animal Group) Diagnostics business places it well for growth in the upcoming quarters. It is also building its global commercial ...